03466nas a2200301 4500008004100000245011500041210006900156260001500225300001000240490000600250520255200256653002002808653001402828653001502842653001602857653001502873653001802888653001702906100002202923700002702945700002902972700002003001700001903021700001903040700002003059700002503079856006003104 2020 eng d00aPrivileges of Pharmacists in Saudi Arabia: Drug Monitoring and Providing Education to Healthcare Professionals0 aPrivileges of Pharmacists in Saudi Arabia Drug Monitoring and Pr cMarch 2020 a55-590 v63 a

Objectives: To explore the privileges of pharmacists with regard to the drug monitoring and providing education to healthcare professionals in Saudi Arabia. Methods: This is a 4-month cross-sectional survey regarding drug monitoring and providing education to healthcare professionals in Saudi Arabia. The study consisted of two parts: the first part collected demographic information and the second part comprised a questionnaire with 28 questions divided into 4 domains. The questions were derived from previous literature and from the regulatory standards of the American Society of Health-System Pharmacists (ASHP). The four domains were as follows: management and resources, pharmacist prescribing and therapeutic interchange, clinical and administration privilege and drug monitoring and healthcare education. The responses were obtained using a 5-point Likert response scale system with close- and open-ended questions. The survey questionnaire was distributed in an electronic format to the director of pharmacy. In this study, we analyzed pharmacist’s privilege with regard to drug monitoring and the education of healthcare providers. All data were obtained through the Survey Monkey system. Results: The survey was distributed to 36 hospitals. Most of the pharmacist’s privilege in drug monitoring and documentation of the clinical impact and cost avoidance was related to patient counseling (90.63%), adverse drug reactions (88.24%) and drug quality reporting (87.50%). Most of the candidates were students from Diploma in Pharmacy (50.00%) followed by (47.22%) pharmacy student and (44.44%) pharmacy technician. Majority of the pharmacists having privileges in providing education and training was available for pharmacists and clinical pharmacists. Finally, pharmacy technicians delivered most of the education and training to general physicians, nurses and specialist physicians. Conclusion: In Saudi Arabia, privileges of a pharmacist with regard to drug monitoring do not exist in various departments of hospitals such as neonates, pediatrics and geriatrics patients. Regular and clinical pharmacists had most of the privileges in providing education and training to the healthcare professionals and few of the healthcare professionals received education and training by the pharmacists. Therefore, there is an increasing demand of a comprehensive awareness program about privileges of a pharmacist in the Kingdom of Saudi Arabia.

10aDrug Monitoring10aEducation10aHealthcare10aPharmacists10aPrivileges10aProfessionals10aSaudi Arabia1 aAl-Otaibi, Faisal1 aImam, Mohamed, Soliman1 aAhmed, Randa, Mansour Ab1 aAlotaibi, Amsha1 aAlotaibi, Asma1 aAlotaibi, Amal1 aAlsuwaid, Wesam1 aAlomi, Yousef, Ahmed uhttp://ptbreports.org/article/2020/6/2/105530ptb2020610